Altogether, our findings demonstrate the ability of MC3 to induce in vitro anti-cancer effects via both p53-dependent (e.g., p38 MAPK activation and apoptosis) and -independent (e.g., cell cycle inhibition) mechanisms. This evidence concerns the gene TP53 and cancer.